期刊文献+

奥卡西平和丙戊酸钠对癫痫患者血浆同型半胱氨酸和不对称二甲基精氨酸水平的影响 被引量:22

Effect of antiepileptic drugs on the level of plasma homocysteine and asymmetric dimethyl arginine in epileptic patients
下载PDF
导出
摘要 目的探讨奥卡西平(OXC)和丙戊酸钠(VPA)对癫痫患者血浆同型半胱氨酸(Hcy)和不对称二甲基精氨酸(ADMA)水平的影响。方法分别检测OXC组32例和VPA组36例单药治疗的癫痫患者血浆Hcy和ADMA水平,与对照组比较,并分析Hcy和ADMA水平与抗癫痫药物治疗时间的相关性。结果 OXC组和VPA组患者血Hcy、ADMA水平高于对照组(P<0.05),OXC组和VPA组比较,差异无统计学意义(P>0.05);抗癫痫药治疗时间与血浆Hcy、ADMA水平均呈正相关(r=0.274、0.256,P<0.05)。结论 OXC和VPA可引起癫痫患者血浆Hcy、ADMA水平升高,长期服用OXC和VPA的癫痫患者应监测血Hcy、ADMA,及时补充B族维生素、叶酸有利于减少血栓事件的发生。 Objective To investigate plasma homocysteine(Hcy)and asymmetric dimethyl arginine(ADMA)concentration in patients with epilepsy receiving oxcarbazepine(OXC)or sodium valproate(VPA)monotherapy.Methods Plasma were collected from 32 cases of OXC and 36 cases of VPA monotherapy.The levels of hcy and ADMA were detected and compared with healthy controls.Then the correlation of the levels and antiepileptic drug treatment duration was analyzed.Results The levels of hcy and ADMA in treatment groups were higher than in control gruops(P〈0.05),and no difference between two treatment groups(P〉0.05).Antiepileptic drug treatment duration and plasma Hcy,ADMA levels were positively correlated(r=0.274,P〈0.05;r=0.256,P〈0.05).Conclusion OXC and VPA elevated hcy and ADMA plasma levels in patients with epilepsy.Routine monitoring of plasma hcy and ADMA and supplementation of B vitamins and folate acid might have help to reduce thrombotic events occurring for patients receiving long-term OXC and VPA therapy.
出处 《重庆医学》 CAS 北大核心 2015年第6期783-784,共2页 Chongqing medicine
关键词 癫痫 奥卡西平 丙戊酸钠 同型半胱氨酸 不对称二甲基精氨酸 epilepsy oxcarbazepine valproate homocysteine asymmetric dimethyl arginine
  • 相关文献

参考文献9

  • 1马如华,卢星文,闫晓英.血浆同型半胱氨酸升高与脑梗死患者颈动脉硬化的关系[J].实用医学杂志,2012,28(4):600-602. 被引量:26
  • 2崔璐华,王庸晋.不对称二甲基精氨酸与动脉粥样硬化[J].国际心血管病杂志,2010,37(2):78-80. 被引量:6
  • 3Dorszewska J,Winczewska-Wiktor A,Sniezaeska A,et al.Homocysteine and asymmetric dimethylarginine( ADMA)in epilepsy[J], Przegl Lek,2009,66(8) :448-452.
  • 4Cheng LS,Prasad AN? Rieder MJ. Relationship betweenantiepileptic drugs and biological markers affecting long-term cardiovascular function in children and adolescents[J]. Can J Clin Pharmacol,2010,17(1) :5-46.
  • 5Belcastro V,Striano P, Gorgone G,et al. Hyperhomocys-teinemia in epileptic patients on new antiepileptic drugs[J]. Epilepsia,2010,51(2) :274-279.
  • 6Oz 0,Gokcil Z,Bek S,et al. Is asymmetric dimethylargin-ine responsible for the vascular events in patients underantiepileptic drug treatment [ J]. Epilepsy Res,2009, 87(1):54-58.
  • 7Ozdemir O, Yakut A’Dinleyici EC,et al. Serum asymmet-ric dimethylarginine ( ADMA) , homocysteine, vitamin B(12),folate levels?and lipid profiles in epileptic childrentreated with valproic acid[J]. Eur J Pediatr, 2011, 170(7):873-877.
  • 8Linnebank M, Moskau S, Semmler A, et al. Antiepilepticdrugs interact with folate and vitamin B12 serum levels[J]. Ann Neurol,2011,69(2) :352-359.
  • 9Volpe SL, Schall JL, Gallagher PR, et al. Nutrient intakeof children with intractable epilepsy compared withhealthy children [ J]. J Am Diet Assoc, 2007 , 107 ( 6 ):1014-1018.

二级参考文献29

  • 1谈晓牧,刘建国,刘怀翔,高海风,张哲成.高同型半胱氨酸血症与脑梗死复发率关系的随访研究[J].中华神经科杂志,2006,39(9):591-594. 被引量:51
  • 2Ueda S, Yamagishi S, Matsumoto Y, et al. Asymmetric dimethylarginine (ADMA) is anovel emerging risk factor for cardiovascular disease and the development of renal injuryin chronic kidney disease[J].Clin Exp Nephrol, 2007, 11(2): 115-121.
  • 3Melikian N,Wheatcroft SB,Ogah OS,et al. Asymmetric dimethylarginine and reduced nitric oxide Bioavailability in young black african men [J].Hypertension, 2007, 49 (4): 873-877.
  • 4Wojciak-Stothard B, Torondel B, Tsang LY, et al. The AD- MA/DDAH pathway is a critical regulator of endothelial cell motility[J]. J Cell Sci, 2007, 120(Pt6) : 929-942.
  • 5Teerlink T. ADMA metabolism and clearance[J]. Vasc Med, 2005, 10(Suppl 1): S73 -S81.
  • 6Kiechl S, Lee T, Santer P, et al. Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population [J].Atherosclerosis, 2009, 205(1) :261-265.
  • 7Barbato JE, Tzeng E. Nitric oxide and arterial disease[J]. J Vasc Surg, 2004, 40(1):187-193.
  • 8Pluta RM. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH[J]. Acta Neurocbir Suppl, 2008, 104: 139-147.
  • 9Veresh Z, Racz A, Lotz G, et al. ADMA impairs nitric oxidemediated arteriolar function due to increased superoxide production by angiotensin II-NAD (P)H Oxidase Pathway [J]. Hypertension, 2008, 52(5):960-966.
  • 10Suda O, Tsutsui M, Morishita T, et al. Asymmetric dimethy-larginine produces vascular lesions in endothelial nitric oxide synthase deficient mice: involvement of reninangiotensin system and oxidative stress [J]. Arterioscler Thromb Vase Biol, 2004, 24(9): 1682-1688.

共引文献30

同被引文献208

引证文献22

二级引证文献115

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部